Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Dario1984
    Senior Member
    • Jun 2011
    • 166

    #16
    Originally posted by GenoMax View Post
    Isaac (http://bioinformatics.oxfordjournals...ent/29/16/2041) was possibly designed for human data but should be usable for other genomes. Illumina has released pre-built indexes only for Hg19 but indexes can be built for other genomes (I have not tried it yet). Isaac aligner in HAS uses 32-mer seeds.
    Another PhD student discovered it doesn't work for the sheep genome, which has | in the name of chromosomes.

    e.g.

    >gi|406684590|gb|CM001582.1| Ovis aries breed Texel chromosome 1, whole genome shotgun sequence
    ATGGGGACATGACCGGGAGGTGGGCAAGGAGAGCGTCTACAGCTCAGGGGAGCCAGGGATCACCGCTCCC ...

    I don't see the point of variant calling for a draft genome, though.

    Comment

    • colindaven
      Senior Member
      • Oct 2008
      • 417

      #17
      So is anyone using Phi in bioinformatics these days ? We do have a great number of compute bound processes (blastx, blastx) in a productive pipeline which could be sped up.

      I do wonder about the utility for typical IO and memory bound bioinformatics applications such as NGS though.

      Comment

      • westerman
        Rick Westerman
        • Jun 2008
        • 1104

        #18
        Originally posted by colindaven View Post
        So is anyone using Phi in bioinformatics these days ? We do have a great number of compute bound processes (blastx, blastx) in a productive pipeline which could be sped up.

        I do wonder about the utility for typical IO and memory bound bioinformatics applications such as NGS though.
        I haven't found a good use for the Phi co-processor. As you imply -- IO and memory bound problems are not a good match.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        44 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Working...